Our Program
Our clinical thalassemia program consists of a pediatric unit and an adult unit, with a seamless transition program connecting the two. Each unit has a dedicated physician, and the program is supported by a practitioner who bridges the two units. Transfusions are administered in state-of-the-art outpatient pediatric and adult infusion centers, supported by NewYork-Presbyterian/Weill Cornell Medicine blood bank and laboratory facilities.
Open Clinical Trials
![Weill Cornell Thalassemia Clinical Trials](/sites/default/files/resize/remote/080d72f43342ba8c36bc8669b1a95ed2-240x304.jpg?itok=JpsuwDW0)
We are committed to advancing thalassemia patient care and facilitating the development of novel treatments through research studies and clinical trials. The development of new strategies, including disease-modifying and curative therapies, form the basis of our progressive approach to thalassemia management for patients at Weill Cornell Medicine.